SCHEMBL12317932

SCHEMBL12317932

Cn1cncc1-c1n[nH]c2cc(C(=O)NCc3ccccn3)ccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITK Q08881 1/20 0.53
▸ RAB9A P51151 3/20 0.51
▸ NPC1 O15118 2/20 0.51
▸ KDM4E B2RXH2 5/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ POLB P06746 3/20 0.51
▸ GAA P10253 2/20 0.51
▸ GLA P06280 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ HSD17B10 Q99714 2/20 0.48
▸ MAPK10 P53779 1/20 0.48
▸ MAPK1 P28482 3/20 0.46
▸ DRD2 P14416 1/20 0.45
▸ NAMPT P43490 1/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ MAPK14 Q16539 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ MAPK3 P27361 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12318101 0.84 ITK (0.51) ITKRAB9ANPC1KDM4EALDH1A1
SCHEMBL12269677 0.82 KDM4E (0.48) ITKRAB9ANPC1KDM4EALDH1A1
SCHEMBL12318479 0.82 ITK (0.61) ITKMAPK1MAPK3ITGB3ITGAV
SCHEMBL12317933 0.82 ATM (0.52) ITKRAB9ANPC1KDM4EALDH1A1
SCHEMBL12317927 0.77 MAP2K4 (0.48) ITKMAPK10MAPK1DRD2MAPK14
SCHEMBL12317929 0.76 MAP2K4 (0.53) ITKRAB9ANPC1KDM4EALDH1A1
SCHEMBL12317931 0.74 GSK3B (0.47) ITKKDM4EPOLBHSD17B10MEN1
SCHEMBL12318045 0.72 MAPK1 (0.45) ITKMAPK1MAPK3
SCHEMBL8252025 0.72 MAPK1 (0.60) RAB9ANPC1KDM4EPOLBHSD17B10
SCHEMBL12907332 0.72 NPC1 (0.65) RAB9ANPC1KDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212961-A1 Pyrazole Derivatives as Kinase Inhibitors BURNHAM INSTITUTE FOR MEDICAL RESEARCH 2011-09-01 — — US disclosed
US-7951832-B2 Pyrazole derivatives as kinase inhibitors BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2011-05-31 — — US disclosed
US-20090124621-A1 PYRAZOLE DERIVATIVES AS KINASE INHIBITORS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124621-A1 PYRAZOLE DERIVATIVES AS KINASE INHIBITORS BRAF, MAP3K1, MAP3K3 ITK 480/4885RAB9A 1267/4885NPC1 1542/4885
US-20110212961-A1 Pyrazole Derivatives as Kinase Inhibitors BRAF, MAP3K1, MAP3K3 ITK 480/4885RAB9A 1267/4885NPC1 1542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback